[Federal Register: November 7, 2002 (Volume 67, Number 216)]
[Notices]               
[Page 67871]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07no02-64]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated April 11, 2002, and published in the Federal 
Register on April 26, 2002, (67 FR 20828), Novartis Pharmaceutical 
Corporation, 59 Route 10, East Hanover, New Jersey 07936, made 
application by renewal to the Drug Enforcement Administration (DEA) to 
be registered as a bulk manufacturer of methylphenidate (1724), a basic 
class of controlled substance listed in Schedule II.
    The firm plans to manufacture finished product for distribution to 
its customers.
    DEA has considered the factors in Title 21, United States Code, 
Section 823a and determined that the registration of Novartis 
Pharmaceutical Corporation to manufacture methylphenidate is consistent 
with the public interest at this time. DEA has investigated Novartis 
Pharmaceutical Corporation on a regular basis to ensure that the 
company's continued registration is consistent with the public 
interest. These investigations have included inspection and testing of 
the company's physical security systems, audits of the company's 
records, verification of the company's compliance with state and local 
laws, and a review of the company's background and history. Therefore, 
pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy 
Assistant Administrator, Office of Diversion Control, hereby orders 
that the application submitted by the above firm for registration as a 
bulk manufacturer of the basic class of controlled substance listed 
above is granted.

    Dated: October 25, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 02-28316 Filed 11-6-02; 8:45 am]

BILLING CODE 4410-09-M